Specialty Overview

Best Hospitals for Stomach Cancer Treatment in Dubai, UAE

3 surgical oncology hospitals in our UAE network are listed in Dubai, accredited by Hospital Certificates of Services, JCI, with 423 beds combined.

3
Hospitals Listed
1
City
4.5
Avg. Rating
2
Accreditation Types
The Short Answer

This page lists the surgical oncology hospitals in our directory offering Stomach Cancer Treatment in Dubai, UAE, including Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai. Each listing links through to the hospital's full profile page.

Ask us about stomach cancer treatment in Dubai, UAE

Share a few details and our care coordination team will get back to you with next steps.

Compare 3 accredited hospitals for Surgical Oncology in Dubai, UAE

🇦🇪 Burjeel Hospital for Advanced Surgery Dubai

Dubai, UAE 4.5 (1 reviews) 209 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by Hospital Certificates of Services209 beds
Specialties & Accreditation
OrthopedicsCardiac SciencesCosmetic SurgeryGastroenterologyGeneral SurgeryGynecology
Accredited by Hospital Certificates of Services
View full profile →
4.5/5
Rating
2014
Established
209
Beds
Dubai, UAE
Location
Kings College Hospital Dubai

🇦🇪 Kings College Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 100 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by Hospital Certificates of Services100 beds
Specialties & Accreditation
Cardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral SurgeryGynecology
Accredited by Hospital Certificates of Services
View full profile →
4.5/5
Rating
2014
Established
100
Beds
Dubai, UAE
Location
Aster Hospital Dubai

🇦🇪 Aster Hospital Dubai

Dubai, UAE 4.5 (1 reviews) 114 beds
Why consider this hospital?
4.5/5 rating from 1 reviewsAccredited by JCI114 beds
Specialties & Accreditation
BariatricCardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral Surgery
Accredited by JCI
View full profile →
4.5/5
Rating
1987
Established
114
Beds
Dubai, UAE
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Stomach Cancer Treatment in Dubai, UAE?

Choosing the right hospital for stomach cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Stomach Cancer Treatment

Stomach cancer (gastric adenocarcinoma) is treated through a multidisciplinary protocol combining surgery, perioperative chemotherapy, targeted therapy, and—where indicated—immunotherapy; experienced oncology centers in India and the UAE achieve 5-year overall survival rates of 30–60% depending on stage at diagnosis. International patients choose GAF Healthcare to access high-volume gastric oncology units staffed by surgeons trained at leading Western and Asian cancer institutes, at a fraction of the cost they would pay at home. GAF Healthcare coordinates every clinical and logistical detail—from staging workup through post-operative surveillance—across its partner network of NABH- and JCI-accredited hospitals in India and JCI- and DHA-licensed centers in Dubai and Abu Dhabi.

10–21 days (varies by extent of resection: distal gastrectomy vs. total gastrectomy, open vs. robotic)
Hospital Stay
4–8 weeks (intercontinental flight is generally permitted once the surgical wound is fully closed, nutritional intake is adequate via oral or enteral route, and the treating surgeon issues medical clearance)
Total Stay in Country (Fit-to-Fly)
Stage I: 70–90% 5-year survival; Stage II: 45–65%; Stage III: 20–40%; Stage IV (palliative intent): median survival 12–18 months with modern systemic therapy
Success Rate

Clinical Overview

Gastric cancer arises predominantly from the glandular epithelium of the stomach lining (adenocarcinoma in ~95% of cases) and is further classified by anatomic location (cardia/gastro-esophageal junction vs. body vs. antrum/pylorus), Lauren histological subtype (intestinal, diffuse, or mixed), and molecular subtype per The Cancer Genome Atlas (TCGA) classification—Epstein-Barr virus-positive, microsatellite instable (MSI-H), chromosomally instable (CIN), and genomically stable (GS). Helicobacter pylori infection, atrophic gastritis, intestinal metaplasia, smoking, high-salt diets, and hereditary diffuse gastric cancer (CDH1 germline mutations) are the principal etiological drivers. Physiologically, tumor growth disrupts gastric acid secretion, impairs digestion, and commonly causes protein-calorie malnutrition; advanced disease may obstruct the gastric outlet or invade adjacent structures (pancreas, transverse colon, liver), producing ascites, peritoneal carcinomatosis, or hepatic metastases.

Full details →

Who is a Candidate?

  • ELIGIBLE FOR CURATIVE SURGICAL RESECTION:
  • Clinical stage IA–IIIC (cT1–T4a, N0–N3, M0) confirmed by EUS, CT, PET-CT, and diagnostic laparoscopy
  • Adequate cardiopulmonary reserve: ECOG performance status 0–2; left ventricular ejection fraction ≥50% (required before anthracycline-based chemotherapy); FEV1 ≥1.0 L for total gastrectomy candidates
  • Nutritional optimization achievable: albumin >3.0 g/dL or correctable with pre-operative enteral nutrition; BMI considerations reviewed by bariatric-oncology team
  • Absence of peritoneal carcinomatosis on diagnostic laparoscopy with negative peritoneal cytology
  • +21 more

Treatment Options & Approaches

Surgical APPROACHES:

1. Distal (Subtotal) Gastrectomy with D2 Lymphadenectomy:

Indicated for tumors of the antrum and pylorus (lower two-thirds of the stomach). At least 4–5 cm proximal margin from the tumor is required. Reconstruction is performed via Billroth II (gastrojejunostomy) or Roux-en-Y configuration to prevent bile reflux. D2 dissection removes lymph node stations 1–12 as defined by the Japanese Gastric Cancer Association (JGCA), and retrieval of a minimum of 16 lymph nodes is required for accurate N-staging. D2 lymphadenectomy is the global standard and is associated with superior disease-specific survival compared to D1 in high-volume centers.

2. Total Gastrectomy with D2 Lymphadenectomy:

Full details →

Recovery

PHASE 1 — PRE-ARRIVAL PREPARATION (Weeks 1–3 before travel):

  • GAF Healthcare coordinator collects existing pathology reports, imaging (CT/PET-CT DICOM files), endoscopy reports, and blood work and submits to the designated oncology team for remote multidisciplinary tumor board review.
  • A written second-opinion report and individualized treatment plan (surgical vs. chemotherapy-first vs. palliative) is issued within 5–7 business days.
  • Visa assistance initiated: e-Medical visa (India) processed in 3–5 business days; UAE entry visa or visa-on-arrival arranged as applicable.
  • Nutritional prehabilitation initiated: patients with albumin <3.0 g/dL begin enteral or high-protein oral supplementation; smoking cessation mandatory.
  • FLOT pre-operative chemotherapy (if applicable) may begin at the patient's home country after protocol review, or at the partner center after arrival.

PHASE 2 — ARRIVAL & STAGING CONFIRMATION (Days 1–4 in country):

Full details →

Risks to be aware of

Stomach cancer surgery and multimodal treatment carry significant risks that patients must discuss in detail with their multidisciplinary team before proceeding. Surgical risks include anastomotic leak (incidence 2–8% after total gastrectomy; managed with radiologically guided drainage or reoperation), duodenal stump blow-out (rare, ~1–2%, life-threatening), intra-abdominal abscess, delayed gastric emptying, and bile reflux gastritis. The Clavien-Dindo classification is used at all GAF partner centers to grade and benchmark post-operative complications; 30-day mortality at high-volume JCI-accredited centers is <2% for elective gastrectomy. Dumping syndrome (early and late) affects 10–20% of patients and requires strict dietary management. Nutritional deficiencies—particularly vitamin B12, iron, calcium, and fat-soluble vitamins—are universal after total gastrectomy and require lifelong supplementation. Chemotherapy-specific risks include peripheral neuropathy (oxaliplatin, cumulative and dose-dependent), febrile neutropenia (FLOT: ~25% incidence; managed with G-CSF), hand-foot syndrome (capecitabine), and cardiotoxicity (anthracyclines used in ECX/ECF regimens, less common with FLOT). Trastuzumab carries a 4–8% risk of asymptomatic left ventricular dysfunction and requires ECHO monitoring every 3 cycles. Immune checkpoint inhibitors (nivolumab, pembrolizumab) may cause immune-related adverse events (irAEs) including immune-mediated pneumonitis, colitis, hepatitis, endocrinopathies, and severe skin reactions (grade 3–4 irAE incidence ~14%); high-dose corticosteroid management protocols are in place at all partner centers. For international patients specifically, the risks of long-haul air travel following major abdominal surgery include deep vein thrombosis (DVT) and pulmonary embolism; all patients traveling internationally post-gastrectomy receive individualized DVT prophylaxis plans including low-molecular-weight heparin, compression stockings, and in-flight mobility guidance. GAF Healthcare's clinical coordinators monitor all patients until fit-to-fly criteria are met and coordinate emergency medical support in the rare event of post-discharge complications.

Why GAF Healthcare

GAF Healthcare provides a dedicated end-to-end non-medical support infrastructure designed specifically for international oncology patients.

Common questions about Stomach Cancer Treatment

What is the cost of Stomach Cancer Treatment in India versus the UAE?
The total cost of stomach cancer treatment depends heavily on the stage of disease, the surgical approach chosen, and the number of systemic therapy cycles required. For surgical treatment (gastrectomy with D2 lymphadenectomy, hospital stay, standard perioperative medications, and routine pre-operative workup), costs in India at JCI- and NABH-accredited centers range from approximately USD 5,000 to USD 18,000. This range covers minimally invasive distal gastrectomy on the lower end and complex open total gastrectomy or multi-visceral resection with robotic assistance on the upper end. In the UAE at JCI- and DHA-licensed hospitals in Dubai and Abu Dhabi, equivalent surgical packages range from USD 12,000 to USD 40,000. India is typically 45–60% more affordable for the same surgical quality and accreditation standards. Importantly, the cost of biological agents and immune checkpoint inhibitors—trastuzumab, trastuzumab deruxtecan, nivolumab, pembrolizumab, or ramucirumab—is quoted separately as it varies significantly based on HER2/MSI/PD-L1 status, weight-based dosing, and number of cycles. A personalized cost estimate for your specific treatment protocol is prepared by GAF Healthcare's clinical team after review of your staging reports and molecular profile.
How long do I need to stay in the country before I am fit to fly home after stomach cancer surgery?
The minimum recommended in-country stay before international air travel following gastric cancer surgery is 4–6 weeks for patients who undergo minimally invasive (laparoscopic or robotic) gastrectomy without complications, and 6–8 weeks for patients who undergo open multi-visceral resection or experience post-operative complications such as anastomotic leak or delayed gastric emptying. Your treating surgical oncologist will issue written fit-to-fly clearance only when all of the following criteria are confirmed: (1) the surgical wound is fully healed with no active drainage or infection; (2) you are tolerating a minimum of 1,000 kcal per day via oral intake or jejunostomy feeding; (3) no anastomotic leak, intra-abdominal abscess, or fluid collection is present on post-operative imaging; (4) your hemoglobin and nutritional parameters are stable; and (5) a DVT prophylaxis plan (low-molecular-weight heparin injection, compression stockings) is in place for the flight. Patients who are also undergoing the first cycles of adjuvant chemotherapy (FLOT cycles 5–8 or CAPOX) at the partner center before returning home may need to extend their stay to 8–12 weeks to complete the initial adjuvant phase. GAF Healthcare's coordinators track all fit-to-fly milestones and assist with airline medical clearance documentation.
What is the success rate of stomach cancer treatment?
Success rates for stomach cancer treatment are highly stage-dependent and are best expressed as 5-year overall survival (OS) rates. At GAF Healthcare's partner centers in India and the UAE—which are high-volume gastric oncology units performing D2 lymphadenectomy as standard—5-year survival rates align with international benchmarks: Stage IA: 85–92%; Stage IB: 70–80%; Stage IIA: 58–68%; Stage IIB: 46–55%; Stage IIIA: 36–45%; Stage IIIB: 22–33%; Stage IIIC: 12–20%; Stage IV (metastatic, systemic therapy intent): median overall survival of 12–18 months with modern combination regimens. For HER2-positive metastatic disease treated with trastuzumab-based therapy, median OS is approximately 14–16 months; for MSI-H/dMMR tumors treated with immune checkpoint inhibitors, a subset of patients (15–25%) achieve durable long-term responses exceeding 3 years. The probability of achieving an R0 (microscopically margin-free) resection—the single most important prognostic surgical factor—exceeds 85% at high-volume centers following adequate pre-operative staging and perioperative FLOT chemotherapy. Pathological complete response (pCR) to neoadjuvant FLOT chemotherapy, achieved in approximately 15–17% of patients, is associated with markedly improved long-term survival. All survival data discussed with patients at GAF partner centers is individualized based on tumor histology, molecular subtype, pTNM stage, and response to initial therapy.

How GAF Healthcare Assists in Choosing the Best Hospital for Stomach Cancer Treatment in Dubai, UAE

Discover the Top Hospitals for Stomach Cancer Treatment in Dubai, UAE

This page lists 3 accredited surgical oncology hospitals in Dubai, UAE, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about stomach cancer treatment in Dubai, UAE

How many surgical oncology hospitals are listed in Dubai, UAE?
3 hospitals in our Dubai, UAE directory are currently listed for surgical oncology including Stomach Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in Dubai, UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in UAE?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there surgical oncology hospitals for this in other UAE cities?
See the "Hospitals in other cities" links on this page for the full UAE list.
🤔

Still have questions?

Our coordinators are here to answer your questions about stomach cancer treatment in Dubai, UAE.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for stomach cancer treatment in Dubai, UAE.

Contact us to report an inaccuracy on this page.